Objective Hypertension (HT) is an important risk factor for target organ damage (TOD). New methods for measuring BP are replacing mercury sphygmomanometry in many clinics. We examined the utility of different BP measurement techniques in predicting subclinical TOD in adolescents and young adults.
Introduction
Hypertension (HT) is an important risk factor for target organ damage (TOD) in children and adults. Autopsy studies such as the Bogalusa Heart Study and the Pathobiologic Determinates of Atherosclerosis in Youth (PDAY) study have demonstrated increased atherosclerosis at higher blood pressure (BP) levels among youth [1, 2] . Other large and well-designed studies have shown higher left ventricular mass (LVM) [3] , greater carotid intima-media thickness (IMT) [3] , stiffer arteries [3] , reduced endothelial function [4] , and renal [5] and neurologic [6] compromise in youth with high BP. Therefore, accurate evaluation of BP levels for the identification of youth at the highest risk of developing TOD is critical, as outlined in current pediatric guidelines for cardiovascular (CV) risk reduction [7] .
New methods for measuring BP, including the use of automatic oscillometric BP (BPo) instruments, are replacing the gold standard, mercury sphygmomanometry (BPm), in many clinics. There are also devices that obtain radial artery pressure curves from which central aortic BP (BPc) is estimated. However, it is not known whether these new techniques are equivalent to mercury sphygmomanometry in their ability to predict TOD in young individuals. Therefore, we sought to determine which method of measuring BP was the most sensitive and specific in identifying subclinical TOD in adolescents and young adults.
Methods
Individuals participating in a study of the CV effects of obesity and type 2 diabetes (T2DM) were evaluated (N = 677). Pregnant women were excluded from the study. Investigational review board approval was obtained, and written informed consent was obtained from participants 18 years or older or from the guardians of participants younger than 18 years. Written assent was obtained for participants younger than 18 years. After an overnight fast, a questionnaire was administered, and anthropometric, BP, laboratory, arterial stiffness, echocardiographic, and carotid ultrasound data were collected.
The mean of two measures of height was obtained with a calibrated stadiometer (Veeder-Rood, Elizabethtown, North Carolina, USA), and the mean of two measures of weight was obtained with a Health-O-Meter electronic scale (Jarden Consumer Solutions, Rye, New York, USA). Laboratory methods for analysis of fasting plasma glucose, insulin, lipid, high-sensitivity C-reactive protein (CRP), and glycated hemoglobin A1c (HbA1c) levels have been published previously [8] . Participants were classified as diabetic according to American Diabetes Association standards [9] . Three measures of resting BP were obtained by trained observers using the same rigorous protocol with mercury sphygmomanometry (BPm; W.A. Baum Co., Copiague, New York, USA), and an oscillometric device (DynaPulse; PulseMetric, San Diego, California, USA) with BP adjusted for differences in oscillometric versus auscultatory technique according to previously published comparison data [10] . The mean of three measures was used in analyses. Central aortic BP was derived by arterial tonometry (SphygmoCor; Atcor Medical, Sydney, Australia). Careful attention was paid to cuff size and measurement technique, as per the Fourth Report on BP in Children [11] or JNC7 [12] . These guidelines specify that the inflatable bladder width should be at least 40% of the arm circumference at a point midway between the olecranon and the acromion [13] . All devices were calibrated according the manufacturer's recommended schedule. BPs from both the oscillometric device [14] and the arterial tonometry device [15] were validated against catheterization data. Interobserver reproducibility of BP measurements was assessed by calculating the coefficients of variation for systolic blood pressure (SBP) and diastolic blood pressure (DBP) for the three readings obtained for each participant. All methods had excellent reproducibility (coefficient of variation in % for SBP: mercury = 1.9, oscillometric = 2.1, central = 1.8; for DBP: mercury = 4.1, oscillometric = 3.4, central = 0.6).
Arterial stiffness measurements
The mean of three resting measures of carotid-femoral pulse wave velocity (PWV) was obtained with a SphygmoCor SCOR-PVx System (Atcor Medical) using directly measured carotid to femoral path length and a pressure tonometer to determine ECG-gated timing of pressure wave propagation, as described previously [8] . Repeat measures in our laboratory show excellent reproducibility, with coefficients of variability less than 7% [8] .
Carotid ultrasonography
Carotid ultrasound studies were performed by a single registered vascular technologist using a high-resolution B-mode ultrasonography system (GE Vivid7; GE Healthcare, Milwaukee, Wisconsin, USA) with a linear array broadband transducer (3.7-8 or 5.6-14 MHz). For each segment (common, bulb, internal), the thickest IMT was recorded as multiple digital loops. Images were read offline using a manual trace technique on the Camtronic Medical systems (Hartland, Wisconsin, USA) software from leading edge to leading edge. The mean of three measures was used in analyses. Composite carotid artery IMT was calculated as the mean of the right and left, common, bulb, and internal carotid artery thicknesses. Our laboratory has measured coefficients of variation of 5.3-8.0% with this technique [16] .
Echocardiography technique
Echocardiography was performed using the same GE system. The absence of structural heart disease was confirmed and then parasternal long-axis and short-axis views were recorded. The mean of three readings of left ventricular end-diastolic dimension, end-diastolic septal, and end-diastolic posterior wall thicknesses were measured offline by either of the two sonographers using a Digiview Image Management and Reporting System (Digisonics, Houston, Texas, USA). LVM was calculated using the Devereaux formula [17] and normalized to ht 2.7 , as recommended by De Simone et al. [18] .
Statistical analysis
Statistical analyses were carried out using statistical analyses software (SAS, version 9.3; SAS, Cary, North Carolina, USA). Participants were stratified as normotensive (N), prehypertensive (P), or hypertensive (H) on the basis of BPm according to pediatric guidelines [7] if less than 18 years and according to JNC7 [12] if 18 years or older. Participants on antihypertensive medication were considered hypertensive regardless of resting BP. BP z-scores were calculated for all three BP measurement techniques using the pediatric guidelines age-specific, sex-specific, and height-specific means. Mean and SD values for the variables were calculated for the entire group and were stratified by HT classification three times (once each by BPm, BPo, and BPc). χ 2 -analyses were carried out to examine differences in the prevalence of HT by BP technique. Analysis of variance was used to determine differences in CV risk factors and subclinical TOD (IMT, LVM, PWV) when participants were classified into a BP group by mercury sphygmomanometry compared with the other two BP measurement techniques. Variance stabilizing measures were used to transform non-normal values. Bivariate Pearson's correlation coefficients were calculated between measures of TOD and the SBP and DBP measured using the three techniques. Participants were categorized as having TOD if their IMT or PWV was greater than or equal to the 95th percentile for our healthy lean participants (N = 250). Cutoff points were derived from our population, as there are no large published pediatric studies of healthy youth from which to define normal values. Left ventricular hypertrophy (LVH) was defined by an LVM of 51 g/m 2.7 or higher [19] according to adult guidelines, as this was similar to the 95th percentile for healthy participants in our study. Logistic regression was performed to determine which BP z-score provided the highest C-statistic (area under the curve) for explaining the presence of measures of TOD. Significant covariates in the correlation analyses were added. Nonsignificant variables were removed until all variables remained at a P-value of up to 0.05. To determine whether the differences in the area under the curve were statistically significant, we used the nonparametric approach of DeLong et al. [20] .
Results
The mean age of the participants was 18 3 years; 35% were male and 60% were non-White, predominantly African-American (1.6% mixed race). Because of the study design, in which youth with T2DM (diagnosed by a primary provider) were recruited (30% of the cohort) and then matched with both a lean and an obese control, this was a relatively obese group with a BMI of 31.0 g/m 2 . As the prevalence of T2DM among adolescents and young adults in Cincinnati is the highest among African-American female individuals, this study design also led to a predominance of this demographic pattern in our cohort. Despite the relative adiposity of the population, the mean BP by mercury sphygmomanometry (115-/64 12/13 mmHg), and the overall low-density lipoprotein (100 29 mg/dl), high-density lipoprotein (50 13 mg/dl), and triglyceride (102 70 mg/dl) levels for the group were within normal limits. Oscillometry yielded the highest prevalence of HT (16%), followed by mercury sphygmomanometry (11%) and central BP measurements (9%). In contrast, mercury sphygmomanometry identified the highest prevalence of prehypertension (20%), followed by central BP measurement (10%) and the oscillometric technique (6%). χ 2 for the oscillometric BP category by central BP category for each level of mercury BP category had P-values of less than 0.0001, indicating that the measurement technique affected the diagnosis of HT in our cohort.
The average values stratified by mercury BP category are presented in Table 1 . Regardless of the BP measurement technique, hypertensive individuals had the most adverse CV risk profile, with a higher BMI, lipid level, and CRP level, and poorer metabolic control (all P values ≤ 0.05). Prehypertensive participants had CV risk factor levels that were generally intermediate to those of participants who were in the normotensive or hypertensive groups. These patterns were consistent for all BP measurement techniques (data not shown). Furthermore, regardless of the BP measurement technique, hypertensive individuals had the most severe level of TOD (thicker IMT, higher LVM and PWV). Carotid IMT was equal in the prehypertensive and hypertensive groups (both higher than that in normotensive individuals) for all BP techniques (prehypertensive and hypertensive > normotensive). LVM was also equal in the prehypertensive and hypertensive groups (both higher than normotensive individuals) when BP was measured by oscillometry (BPo) or centrally (BPc). However, BP measured by mercury sphygmomanometry (BPm) was able to distinguish between all three categories (LVM for hypertensive > prehypertensive > normotensive). Similarly, both BPm and BPo yielded differences in PWV among all groups (hypertensive > prehypertensive > normotensive), but BPc did not (all P values ≤ 0.05). This is graphically shown for LVM in Fig. 1 .
When TOD was defined by cutoff points, 11% had a thick IMT, 6.2% had LVH, and 24% had elevated PWV. Correlations between BP z-scores and TOD were similar in magnitude and significance for all BP measurement techniques (data not shown, all P values ≤ 0.05). In fully adjusted logistic regression models ( Table 2) , mercury SBP z-score (for LVH) and mercury DBP z-score (for higher IMT and PWV) provided the greatest sensitivity and specificity (highest C-statistic) in predicting the TOD of interest. Additional covariates that entered the models included the following: the presence of T2DM for IMT, T2DM, BMI z-score, and heart rate for LVM and race, BMI z-score, triglyceride, glucose, and CRP levels, and race by CRP interaction for PWV. The C-statistic for mercury SBP predicting LVM was significantly higher than that for oscillometric or central BP (Fig. 2) . There was no difference in the C-statistic for PWV or IMT.
Discussion
Our data demonstrate that when evaluated statistically, mercury BP measurements may be more sensitive and specific in predicting which participants may have TOD compared with oscillometric and central BP measurements in young patients. However, the magnitude of benefit in using mercury to predict TOD may not be clinically relevant. That said, there are other important reasons for recommending the use of mercury sphygmomanometers to measure BP levels in children. First, normal values of BP in youth are based on mercury BP values [7] . Second, there are insufficient normative data in youth to establish cutoff points for oscillometric and central BP levels.
Many adult experts continue to recommend mercury sphygmomanometer usage because oscillometric devices need periodic calibration (every 6 months) [21] , which often can only be performed by the manufacturer [22] . Our devices were maintained according to the manufacturer's recommendations. Failure to perform periodic calibration may result in misclassification rates ranging from 15 to 31% [23] . In addition, few devices have been validated in children (http://www.dableducational.org/), and one study suggested that agreement depended upon the participants' mean BP level, with more underestimation of SBP in hypertensive and overestimation of SBP in normotensive youth [24] . Agreement between mercury and automatic devices also varies by device, from nearly identical [25] to as much as a 10 mmHg difference [26] . The direction of the difference also varies, with some devices consistently overestimating SBP [27, 28] or DBP [29] compared with a mercury sphygmomanometer and others underestimating SBP [30, 31] or DBP [32, 33] . There also appears to be a 'first reading effect', with the difference between the automatic device and the mercury sphygmomanometer diminishing on subsequent automatic recordings of BP [32] . Although the Dynapulse device has not undergone strict validation testing according to either protocol, it has been applied simultaneously with mercury sphygmomanometry in large epidemiologic studies, and a high reliability coefficient (0.85) and excellent precision (SBP and DBP within 5 mmHg of mercury BP measurements) was found [10] . Furthermore, we used the 'auscultatory equivalent' BP levels supplied by the device manufacturer, which were 'calibrated' using Bogalusa Heart Study data in over 1000 individuals to be closer to mercury BP levels.
The consequence of error in BP measurement is that patients may be misclassified as being normotensive or having HT [34, 35] . Current validation protocols give devices a passing grade even though the difference between the device and a mercury sphygmomanometer is greater than 5 mmHg up to 30% of the time [36, 37] . Although small systematic differences may not seem clinically relevant, they can result in substantial errors in diagnosis in children as there is a narrow range between the percentiles defining prehypertension and true hypertension [7, 38] . Therefore, it is not surprising that a study of high-risk children with chronic kidney disease found that oscillometric and mercury devices agreed on BP classification only 60% of the time [39] . Furthermore, oscillometric machines have proven less accurate in settings of increased vascular stiffness [40] . This would suggest that these types of devices may be less useful in identifying patients with HT-related arterial stiffening.
Use of estimated central aortic BP values in risk stratification is increasing in adults with HT [41] , as central BP may be superior in predicting CV events [42] . This is because intervention on the basis of BP measured closer (central) to a target organ (i.e. the heart) may have a greater effect on reversing TOD [43] . However, centralto-peripheral BP difference may be greater in hypertensive as compared with normotensive adults [44] . We also found a greater central-peripheral difference at higher BP levels (peripheral-central SBP for normotensive adults = 9.4 mmHg, prehypertensive adults = 15.6 mmHg, hypertensive adults = 17.7 mmHg). However, despite the apparent superiority of central BP measurements in predicting events in adults, according to our data, participants classified by mercury BP measurements were more likely to have TOD. Therefore, until more data on young individuals is available, we question the appropriateness of classifying young patients on the basis of central BP measures.
Limitations
Large-scale multiracial studies defining normal values for oscillometric and central BP levels in adolescents and young adults are lacking. Therefore, we used the most up-to-date pediatric guidelines [7] to obtain our BP z-scores. Although oscillometric BP values may be higher and central BP values may be lower due to pulse wave amplification along the arterial tree [41] , calculating z-scores using data from the pediatric guidelines (N = 63 227) would not change the rank order of the participants; thus, this approach is still statistically robust. Using our lean participants to derive z-scores would be problematic, as stratifying this small number of individuals (N = 275) by sex and height would lead to z-scores with wide confidence intervals, possibly leading to inaccuracies in BP and height classifications by the BPo and BPc techniques.
Another limitation is the lack of clear-cut points to define TOD in youth. We used the adult cutoff point for LVH of 51 g/m 2.7 , which is heavier than the 95th percentile for LVM in healthy children (39.4 g/m 2.7 for male and 40.0 g/m 2.7 for female individuals ≥ 16 years) [45] . This is a more conservative approach. There are no published guidelines defining increased IMT in youth. However, in 635 adolescents and young adults of the Muscatine Offspring Study [46] , the mean (0.49 mm) and SD (0.04) for composite IMT yielded a 95th percentile value of 0.556 mm, similar to the 95th percentile of 0.565 mm used in our study. Few studies on PWV in youth have been published. Regression equations from two large adult studies that included individuals between 18 and 21 years of age resulted in an estimated 95th percentile for PWV between 5.66 and 5.99 m/s among 18-year-olds [47, 48] . We used a value of 6.57 m/s, obtained from healthy lean participants in our cohort, a more conservative estimate.
Our cohort of one in three diabetic participants represents a higher risk group than seen in the average pediatrician's office. This may limit generalizability, although there is no reason to suspect that BP levels are related to TOD in a different manner in diabetic patients as compared with nondiabetic individuals. In addition, measurements were taken by trained research assistants, which may not reflect the conditions in an average practitioner's office. However, all three BP measurements were taken by the same research assistant on the same day, thus reducing this potential bias. Some researchers suggest that many young patients with 'high BP', especially tall, thin, male patients, may actually have 
ROC curves for comparisons
ROC curves for LVM by SBP z-score using three methods of measuring BP. Unadjusted models.*All models P ≤ 0.0001. Models are unadjusted. BP, blood pressure; LVM, left ventricular mass; Osc, oscillometric; ROC, receiver operating characteristic; SBP, systolic blood pressure. a benign condition called 'spurious HT' (hypertensive brachial BP value with normal central BP), which is associated with normal arterial stiffness [49] . We found only three participants who were hypertensive by mercury SBP measurements and normotensive by central BP measurements (data not shown), none of whom were tall or thin; therefore, we do not believe that this is a major factor confounding our results.
Conclusion
Further large-scale studies are needed to develop normative data for oscillometric and central BP levels in adolescents and young adults, as many institutions are removing mercury devices from use due to safety concerns and their operator dependence. This is one reason to continue using mercury sphygmomanometers for evaluation of risk for hypertensive TOD. However, oscillometric and central BP measures are related to TOD in a similar manner to mercury BP measures and may be a suitable substitute in situations in which mercury devices are prohibited.
